About us

Profile (as of April 2021)

Company name Lilac pharma Inc.
Address Room #C, Hokkaido Collaboration Center (Collabo Hokkaido Bldg.)
North 21, West 12, Kita-ku, Sapporo, Hokkaido 001-0021, Japan
Business 1. Research and development of pharmaceutical products etc.
2. Licensing and trading intellectual properties.
3. Investigation and consultation pertaining to the research and development of pharmaceutical products etc.
Date of establishment April 18, 2016
Capital 14.1 million yen
Management President  Motoki Susa, PhD
Director  Makiyo Sato,

Auditor  Taihei Muramoto, SME Management Consultant
Adviser Hisao Shiozawa, Patent attorney, SIKS &Co. (IP firm)
Employee 3


Mar. 2016 Awarded the Grand Prize in the SAPPORO Venture Grand Prix 2015 (in the name of Motoki Susa).
Mar. 2016 Awarded a grant of 35 million yen from the NEDO (New Energy and Industrial Technology Development Organization, Japan) (in the name of Hokkaido univ. entrepreneur team).
Apr. 2016 Established in Sapporo city.
Jun. 2016 Certified by Hokkaido University as a university spin-off company.
Jan. 2018 Raised 10 million yen in seed-round financing from Hokuyo fund.
Apr. 2018 iLiNP business launched.

Origin of Company name

Lilac likes a cool place and we can see mainly in Hokkaido, Japan. It was chosen as a “Tree of Sapporo city” in 1960 and it is familiar to many citizens now.

Lilac’s petals are usually 4 pieces, but rarely 5 pieces. If you find the rare flower and swallow it silently, it’s said that you can spend eternally with a person who loves.

We’d like to create the pharmaceutical products, which become the “5th Lilac petal” for patients, and decided to include our feelings in this Company’s name.


Copyright © ライラックファーマ株式会社 All Rights Reserved.
Powered by WordPress & BizVektor Theme by Vektor,Inc. technology.